Current Medicinal Chemistry - Anti-Cancer Agents
Title: Preface [Hot topic:Drug Resistance in Cancer Therapy (Guest Editor: Jian-Ting Zhang)]
Volume: 4 Issue: 1
Author(s): Jian-Ting Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang Jian-Ting, Preface [Hot topic:Drug Resistance in Cancer Therapy (Guest Editor: Jian-Ting Zhang)], Current Medicinal Chemistry - Anti-Cancer Agents 2004; 4 (1) . https://dx.doi.org/10.2174/1568011043482179
DOI https://dx.doi.org/10.2174/1568011043482179 |
Print ISSN 1568-0118 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5968 |
10
Related Articles
-
Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese
Current Molecular Medicine The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function
Endocrine, Metabolic & Immune Disorders - Drug Targets The ARRONAX Project
Current Radiopharmaceuticals Living Life to the Fullest: Early Integration of Palliative Care into the Lives of Children with Chronic Complex Conditions
Current Pediatric Reviews Effects of Palmitoylethanolamide and Luteolin in an Animal Model of Anxiety/Depression
CNS & Neurological Disorders - Drug Targets New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Current Drug Targets A Uniquely Modified DKL-based Peptide Probe for Positron Emission Tomography Imaging
Current Pharmaceutical Design Promoting Inter-/Intra- Cellular Process of Nanomedicine through its Physicochemical Properties Optimization
Current Drug Metabolism The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Current Neuropharmacology Natural Proteinaceous Inhibitors of Serine Proteases
Current Pharmaceutical Design Preparation and Characterization of PEGylated C18 Fatty Acids/Anti-SNAP25 Antibody-Targeted Liposomes
Current Chemical Biology Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)].
Current Pharmaceutical Design Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer
Current Cancer Therapy Reviews Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
Current Pharmaceutical Design Editorial (Thematic Issue: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets)
Current Alzheimer Research A Systems Pharmacology Analysis of Major Chemotherapy Combination Regimens Used in Gastric Cancer Treatment: Predicting Potential New Protein Targets and Drugs
Current Cancer Drug Targets S2SNet: A Tool for Transforming Characters and Numeric Sequences into Star Network Topological Indices in Chemoinformatics, Bioinformatics, Biomedical, and Social-Legal Sciences
Current Bioinformatics Application of Chemistry-Based Functional Proteomics to Screening for Novel Drug Targets
Combinatorial Chemistry & High Throughput Screening Nanotechnology Based Diagnostic and Therapeutic Strategies for Neuroscience with Special Emphasis on Ischemic Stroke
Current Medicinal Chemistry Drug Interactions with Normal and TEN Epidermal Keratinocytes
Current Drug Safety